Literature DB >> 8539672

Effects of propranolol inhalation on the diurnal increase in FEV1 and on propranolol airways responsiveness in atopic subjects with asthma.

Y Oosterhoff1, G H Koëter, D S Postma.   

Abstract

BACKGROUND: Propranolol inhalation provocation tests are used to measure indirect airways responsiveness in the investigation of asthma. In this study the effects of repeated propranolol inhalation provocation tests within the same day on normal diurnal variation in the forced expiratory volume in one second (FEV1) and subsequent propranolol airways responsiveness were investigated.
METHODS: Fifteen atopic asthmatic subjects were challenged with doubling concentrations of propranolol at 08.00 and 16.00 hours on the same study day and at 16.00 hours on a control day to exclude changes related to normal diurnal variation.
RESULTS: Mean (SD) baseline FEV1 at 16.00 hours on the study day was 3.38 (0.23) 1, significantly lower than the value at 16.00 hours on the control day of 3.70 (0.24) 1 (p = 0.001). No differences were found between the geometric mean provocative concentration of propranolol causing a 20% fall in FEV1 (PC20) measured on the study day (08.00 hours, 9.3 mg/ml; 16.00 hours, 11.3 mg/ml) and on the control day (16.00 hours 9.3 mg/ml).
CONCLUSIONS: The results suggest that propranolol provocation at 08.00 hours has a long lasting effect on FEV1, thereby counteracting the normal diurnal increase in diameter of the airways. This makes propranolol challenge tests less suitable for studying indirect airways responsiveness in the course of one day. Because the FEV1 does not return to control values, it is not possible to determine whether tachyphylaxis to repeated propranolol challenge with a time interval of up to eight hours occurs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539672      PMCID: PMC1021305          DOI: 10.1136/thx.50.9.937

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

Review 1.  Mechanisms of beta-adrenergic receptor regulation in lungs and its implications for physiological responses.

Authors:  F P Nijkamp; F Engels; P A Henricks; A J Van Oosterhout
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

2.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

3.  The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample.

Authors:  B Rijcken; J P Schouten; S T Weiss; F E Speizer; R van der Lende
Journal:  Am Rev Respir Dis       Date:  1987-07

4.  Tachyphylaxis to inhaled histamine in asthmatic subjects.

Authors:  P J Manning; G L Jones; P M O'Byrne
Journal:  J Appl Physiol (1985)       Date:  1987-10

5.  Provocative dose and dose-response curve to inhaled propranolol in asthmatic patients with bronchial hyperresponsiveness to methacholine.

Authors:  A Foresi; A Chetta; G M Corbo; A Cuomo; D Olivieri
Journal:  Chest       Date:  1987-09       Impact factor: 9.410

6.  A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity.

Authors:  M Okayama; N Yafuso; H Nogami; Y N Lin; S Horio; W Hida; H Inoue; T Takishima
Journal:  J Allergy Clin Immunol       Date:  1987-09       Impact factor: 10.793

7.  Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol.

Authors:  P Barnes; G FitzGerald; M Brown; C Dollery
Journal:  N Engl J Med       Date:  1980-07-31       Impact factor: 91.245

Review 8.  Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma.

Authors:  R Pauwels; G Joos; M Van der Straeten
Journal:  Clin Allergy       Date:  1988-07

9.  Increased responsiveness to histamine after propranolol in subjects with asthma nonresponsive to the bronchoconstrictive effect of propranolol.

Authors:  G Carpentiere; F Castello; S Marino
Journal:  J Allergy Clin Immunol       Date:  1988-10       Impact factor: 10.793

10.  Protective effect of disodium cromoglycate on propranolol challenge.

Authors:  G H Koëter; H Meurs; J G de Monchy; K de Vries
Journal:  Allergy       Date:  1982-11       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.